GlassScriptPhysician profile
Brittany Korell
NPI 1396475018
$1,479.74
in general payments reported to CMS, 2019-2025
14 companies · $474 in 2025
The $474 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $146 · 2023: $261 · 2024: $598 · 2025: $474.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,333.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,333.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $521.80 | 2024-2025 | Intracept |
| Saluda Medical Americas, INC. | $220.47 | 2025 | Evoke |
| Medtronic, INC. | $202.14 | 2022-2023 | Intellis Adaptivestim, In.Pact Admiral, Synchromedii |
| Acadia Pharmaceuticals INC | $119.53 | 2024 | Nuplazid |
| Otsuka America Pharmaceutical, INC. | $101.86 | 2024 | Nuedexta |
| Merck Sharp & Dohme LLC | $74.49 | 2022-2023 | Verquvo |
| Abbvie INC. | $54.68 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $48.26 | 2022-2023 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.28 | 2022-2023 | Jardiance |
| Spinal Simplicity, LLC | $34.58 | 2025 | Ha Minuteman G3-R |
| Stryker Corporation | $19.32 | 2025 | Mild Device Kit |
| Bayer Healthcare Pharmaceuticals INC. | $19.01 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $14.43 | 2023 | Austedo Xr |
| Astrazeneca Pharmaceuticals LP | $13.89 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittany Korell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.